Nuevolution

Nuevolution is a leading small molecule lead discovery company, established in 2001, with its headquarters located in Copenhagen, Denmark. The company has developed Chemetics®, a patented and unique mixture that combines proven wet chemistry and molecular biology properties, representing the ultimate fragment-based drug discovery technology. Chemetics® enables rapid synthesis and DNA tagging of hundreds of millions of chemically diverse drug-like small molecule compounds, allowing for highly efficient screening compared to existing drug discovery technologies. This facilitates the identification of potent drugs with unprecedented scale, quality, and speed. Currently, Nuevolution's library contains over one billion small molecule compounds and synthetic biologics available for screening. Nuevolution collaborates with pharmaceutical and biotechnology companies to further develop its technology.